GlassScriptPhysician profile
Victor Wowk
NPI 1528002383
$3,029.43
in general payments reported to CMS, 2019-2025
24 companies · $475 in 2025
The $475 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $162 · 2021: $699 · 2022: $322 · 2023: $619 · 2024: $270 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,364.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $780.79 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Pangea |
| Innovation Technologies INC | $226.14 | 2023 | Irrisept |
| Biocomposites INC | $225.92 | 2023 | Stimulan |
| Arthrex, INC. | $218.90 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $210.64 | 2022-2025 | Euflexxa |
| Amgen INC. | $200.62 | 2023-2025 | Evenity, Prolia, Krystexxa |
| Depuy Synthes Sales INC. | $184.14 | 2019-2024 | Trumatch |
| Pacira Pharmaceuticals Incorporated | $168.56 | 2019-2025 | Exparel, Zilretta, Iovera |
| Globus Medical, INC. | $150.00 | 2021 | |
| Si-Bone, INC. | $144.92 | 2021 | |
| Pacira Therapeutics, INC. | $107.84 | 2019-2020 | |
| Providence Medical Technology, INC. | $60.08 | 2021 | |
| Tactile Systems Technology INC | $57.14 | 2019 | |
| Ethicon US, LLC | $41.61 | 2025 | Surgiflo Hemostatic Matrix, Surgicel Nu-Knit, Vistaseal |
| Smith+Nephew, INC. | $37.96 | 2022-2023 | Pico 14, Pico 7 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $32.99 | 2021 | |
| 4web, INC. | $29.18 | 2021 | |
| Bioventus LLC | $28.51 | 2022 | |
| Intrinsic Therapeutics | $24.68 | 2023 | Barricaid Acd (Annular Closure Device) |
| Fidia Pharma USA INC. | $22.05 | 2025 | Triluron, Hymovis |
| Ermi LLC | $20.86 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $20.30 | 2025 | |
| Vertos Medical, INC. | $17.88 | 2022 | |
| Medtronic USA, INC. | $17.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Wowk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.